Item talk:Q167141

{

 "OpenAlex": {
   "display_name": "Management of Hyperkalemia in Kidney Diseases",
   "description": "This cluster of papers focuses on the management of hyperkalemia, particularly in patients with kidney diseases. It covers various aspects such as the use of renin-angiotensin-aldosterone system inhibitors, potassium homeostasis, and the effectiveness of treatments like sodium zirconium cyclosilicate and patiromer. Additionally, it explores the association of hyperkalemia with conditions like chronic kidney disease, heart failure, and gastrointestinal adverse events.",
   "keywords": [
     "Hyperkalemia",
     "Renin-Angiotensin-Aldosterone System Inhibitors",
     "Potassium Homeostasis",
     "Sodium Zirconium Cyclosilicate",
     "Patiromer",
     "Chronic Kidney Disease",
     "Electrolyte Disorders",
     "Gastrointestinal Adverse Events",
     "Heart Failure",
     "Esophageal Necrosis"
   ],
   "ids": {
     "openalex": "https://openalex.org/T12876",
     "wikipedia": "https://en.wikipedia.org/wiki/Hyperkalemia"
   },
   "subfield": {
     "id": "https://openalex.org/subfields/2740",
     "display_name": "Pulmonary and Respiratory Medicine"
   },
   "field": {
     "id": "https://openalex.org/fields/27",
     "display_name": "Medicine"
   },
   "domain": {
     "id": "https://openalex.org/domains/4",
     "display_name": "Health Sciences"
   },
   "updated_date": "2024-08-12T06:03:45.262388",
   "created_date": "2024-01-23",
   "type": "topic",
   "oa_id": "T12876",
   "id": "https://openalex.org/T12876"
 }

}